ASX Announcement 21 October 2026 Update on Commercial Terms for the Proposed Merger with Microba Life Sciences • Genetic Signatures Limited (ASX: GSS) (GSS) and Microba Life Sciences Limited (ASX: MAP) (Microba) have agreed, in principle, to revised terms for the proposed merger, under which...
Update on Commercial Terms for Proposed Merger with MAP
Filed with ASX · · 2 pages · English
Release
Microba Life Sciences Limited on 6ix
Story so far
Earlier from Microba Life Sciences
- Proposed issue of securities - MAP
- Q1 FY27 Quarterly Activities Report & Appendix 4C
- Microba secures $2m placement and increases cost reductions
- Date of AGM and closing date for Director Nominations
- Notification of cessation of securities - MAP
Later from Microba Life Sciences
- Final Director's Interest Notice - Gene Tyson
- Final Director's Interest Notice - Ian Frazer
- Letter to Shareholders, Notice of AGM & Proxy Form
- Application for quotation of securities - MAP
- Cleansing Notice
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences